Section Arrow
NDRA.NASDAQ
- ENDRA Life Sciences
Quotes are at least 15-min delayed:2024/04/27 13:21 EDT
Last
 0.2525
+0.01 (+4.12%)
Day High 
0.257299 
Prev. Close
0.2425 
1-M High
Volume 
11.10K 
Bid
0.2476
Ask
0.26
Day Low
0.2422 
Open
0.252 
1-M Low
0.221 
Market Cap 
2.68M 
Currency USD 
P/E -- 
%Yield
10-SMA 0.26 
20-SMA 0.33 
50-SMA 0.78 
52-W High 2.79 
52-W Low 0.221 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.58/-1.52
Enterprise Value
2.87M
Balance Sheet
Book Value Per Share
0.51
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LABStandard BioTools2.44+0.08+3.39%-- 
DHRDanaher Corp246.58+0.78+0.32%45.1PE
ME23andMe Holding Co0.4641+0.0051+1.11%-- 
NEOGNeogen Corp12.14+0.18+1.51%598PE
EXASExact Sciences Corp58.85+0.06+0.10%-- 
Quotes are at least 15-min delayed:2024/04/27 13:21 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH),chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.